SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.36 |
| Enterprise Value ($M) | 6.73 |
| Book Value ($M) | -14.91 |
| Book Value / Share | -0.31 |
| Price / Book | -0.22 |
| NCAV ($M) | -14.23 |
| NCAV / Share | -0.30 |
| Price / NCAV | -0.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.12 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.24 |
| Current Ratio | 0.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.11 |
| Assets | 6.53 |
| Liabilities | 18.34 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Before Distributed Earnings Diluted | n/a |
| Earnings Per Share Basic Distributed | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Before Distributed Earnings Basic | n/a |
| Earnings Per Share Diluted Distributed | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.99 | 54.35 | |
| 13G/A | Lind Global Fund II LP | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 77,800 | 407,922 | 19.07 | |
| 16,724 | 27,515 | 60.78 | |
| 4,723 | 19,512 | 24.21 | |
| 6,827 | 101,210 | 6.75 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AOBI – American Oriental Bioengineering, Inc. | AOLS – Aeolus Pharmaceuticals, Inc. |
| AOXG – Aoxing Pharmaceutical Company, Inc. | ARGNF – argenx SE |
| ARNI – Arno Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io